Digital subtraction angiography C-arm catheterization suite for TACE and HAIC

CLINICAL APPLICATION & CRITERIA

Minimally Invasive Interventional & Ablation Therapy in China

Interventional oncology uses image-guided, minimally invasive procedures performed through small punctures to treat tumors directly, without open surgery. Under CT, ultrasound, or digital subtraction angiography (DSA) guidance, interventional radiologists deliver treatment through catheters, needles, or probes — including transarterial chemoembolization (TACE), radiofrequency and microwave ablation, cryoablation, irreversible electroporation (NanoKnife), and portal vein embolization. These techniques can be curative for small localized tumors, used as a bridge to transplant, or applied palliatively to control symptoms and extend survival in patients who are not surgical candidates.

  • Minimally Invasive Access
  • Ablative Treatment for Selected Tumors
  • Transarterial Chemoembolization (TACE)
  • Organ Function Preservation
  • Repeatable & Combinable
  • Short Hospital Stay

CLINICAL CANCER INDICATIONS

Key Cancers Treated with Interventional & Ablation Therapy in China

Minimally invasive arterial infusion chemotherapy, thermal ablation, and non-thermal electroporation delivered under real-time imaging guidance:

Liver Cancer

Hepatic Arterial Infusion Chemotherapy (HAIC) and drug-eluting bead TACE delivering 20x higher localized drug exposure for unresectable HCC.
Learn More

Lung Cancer

CT-guided percutaneous microwave ablation and cryoablation for inoperable primary lung nodules and multiple oligometastatic pulmonary lesions.
Learn More

Stomach & Colorectal Cancer

Non-thermal NanoKnife irreversible electroporation (IRE) safe for borderline pancreatic cancer adjacent to celiac and mesenteric blood vessels.
Learn More

WHY CHOOSE US

Why Choose China Cancer Help for Interventional & Ablation Therapy

A specialized cross-border continuum connecting international patients directly with China’s world-leading interventional oncology centers.

China bears the world’s highest burden of hepatocellular carcinoma (HCC), giving its interventional radiologists unmatched experience in TACE, drug-eluting bead TACE (DEB-TACE), hepatic arterial infusion chemotherapy (HAIC), and ablation. Chinese guidelines on interventional treatment of liver cancer are internationally recognized and widely cited. Many leading Grade 3A hospitals operate well-equipped interventional radiology departments with the latest DSA, CT fusion, and ablation systems, and domestic manufacturers produce high-quality devices at competitive prices.

Beyond HCC, Chinese centers have extensive expertise in ablation for lung and renal tumors, NanoKnife for pancreatic cancer, and interventional pain management for bone metastases. The cost of interventional procedures is substantially lower than surgery, and the minimally invasive nature makes treatment accessible to elderly patients and those with comorbidities who cannot tolerate major operations. Bilingual coordinators at leading centers ensure international patients receive seamless evaluation, treatment, and follow-up care.

CASE EVALUATION PATHWAY

A Structured Pathway from Records to Care

A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international Interventional & Local Therapies patients considering care in China.

By infusing chemotherapy directly into the tumor-feeding arterial branches, local drug concentrations in liver tumors are up to 20 times higher than systemic administration, while first-pass hepatic extraction substantially reduces systemic toxicity.
Yes. One of the greatest benefits of interventional oncology (TACE, ablation, seed implantation) is that procedures are repeatable and can be combined sequentially with systemic targeted therapy and immunotherapy without exhausting normal organ reserve.
Procedures are minimally invasive, requiring only a tiny skin puncture under local or moderate sedation. Most patients mobilize within 4 to 6 hours and are discharged within 24 to 48 hours.
Unlike thermal ablation, NanoKnife relies on non-thermal electric pulses to open nanoscale pores in tumor cell membranes, sparing extracellular collagen scaffolds, major blood vessels, and bile ducts from heat sink effects or thermal injury.

INTERVENTIONAL & ABLATION THERAPY PRE-ASSESSMENT

Request a Confidential Case Review for Interventional & Ablation Therapy

Submit your contact details, confirmed diagnosis, and main question below. You do not need to upload any medical files at this stage. Our clinical coordinator will contact you directly within 24–48 hours to discuss potential interventional and local ablative pathways in China and assist you in gathering the specific medical records needed for expert hospital review.

    Interventional & Local Therapies